Systematic identification of engineered methionines and oxaziridines for efficient, stable, and site-specific antibody bioconjugation
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Systematic identification of engineered methionines and oxaziridines for efficient, stable, and site-specific antibody bioconjugation
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume -, Issue -, Pages 201920561
Publisher
Proceedings of the National Academy of Sciences
Online
2020-03-03
DOI
10.1073/pnas.1920561117
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Physical Organic Approach to Tuning Reagents for Selective and Stable Methionine Bioconjugation
- (2019) Alec H. Christian et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- High-Throughput Cysteine Scanning To Identify Stable Antibody Conjugation Sites for Maleimide- and Disulfide-Based Linkers
- (2018) Rachana Ohri et al. BIOCONJUGATE CHEMISTRY
- Fate of Antibody-Drug Conjugates in Cancer Cells
- (2018) Cécile Chalouni et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Evidence of disulfide bond scrambling during production of an antibody-drug conjugate
- (2018) Lily Pei-Yao Liu-Shin et al. mAbs
- A protein functionalization platform based on selective reactions at methionine residues
- (2018) Michael T. Taylor et al. NATURE
- The return of gemtuzumab ozogamicin: a humanized anti-CD33 monoclonal antibody–drug conjugate for the treatment of newly diagnosed acute myeloid leukemia
- (2018) Pamela C Egan et al. OncoTargets and Therapy
- Simultaneous epitope and transcriptome measurement in single cells
- (2017) Marlon Stoeckius et al. NATURE METHODS
- Strategies and challenges for the next generation of antibody–drug conjugates
- (2017) Alain Beck et al. NATURE REVIEWS DRUG DISCOVERY
- Redox-based reagents for chemoselective methionine bioconjugation
- (2017) Shixian Lin et al. SCIENCE
- Antibody-siRNA conjugates: drugging the undruggable for anti-leukemic therapy
- (2016) Jogender Tushir-Singh EXPERT OPINION ON BIOLOGICAL THERAPY
- Simultaneous Multiplexed Measurement of RNA and Proteins in Single Cells
- (2016) Spyros Darmanis et al. Cell Reports
- Antibody-drug conjugates: recent advances in conjugation and linker chemistries
- (2016) Kyoji Tsuchikama et al. Protein & Cell
- Effect of Individual Fc Methionine Oxidation on FcRn Binding: Met252 Oxidation Impairs FcRn Binding More Profoundly than Met428 Oxidation
- (2015) Xuan Gao et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- A High Through-put Platform for Recombinant Antibodies to Folded Proteins
- (2015) Michael Hornsby et al. MOLECULAR & CELLULAR PROTEOMICS
- In Vitro and In Vivo Evaluation of Cysteine Rebridged Trastuzumab–MMAE Antibody Drug Conjugates with Defined Drug-to-Antibody Ratios
- (2015) Penny Bryant et al. MOLECULAR PHARMACEUTICS
- Assessment of chemical modifications of sites in the CDRs of recombinant antibodies
- (2014) Markus Haberger et al. mAbs
- Selective chemical protein modification
- (2014) Christopher D. Spicer et al. Nature Communications
- Site-specific antibody drug conjugates for cancer therapy
- (2013) Siler Panowski et al. mAbs
- CDR-H3 Diversity Is Not Required for Antigen Recognition by Synthetic Antibodies
- (2012) Helena Persson et al. JOURNAL OF MOLECULAR BIOLOGY
- Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates
- (2012) Ben-Quan Shen et al. NATURE BIOTECHNOLOGY
- Neonatal Fc receptor and IgG-based therapeutics
- (2011) Timothy T. Kuo et al. mAbs
- Brentuximab Vedotin (SGN-35) for Relapsed CD30-Positive Lymphomas
- (2010) Anas Younes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody-Cytotoxic Drug Conjugate
- (2008) G. D. Lewis Phillips et al. CANCER RESEARCH
- Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index
- (2008) Jagath R Junutula et al. NATURE BIOTECHNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started